By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...
Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...
Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
The Vancouver Sun on MSN
Cheaper, generic versions of Ozempic and Wegovy are coming. Here's what that means for B.C.
British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs.
Calgary Herald on MSN
Ozempic and Wegovy-type generic drugs could drop prices by a third, says Calgary doctor
Albertans may see more varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago.
The post “A Godsend”: ProPublica’s Rx Inspector Tool Is Helping People Find Critical Safety Information on Generic Drugs ...
The post ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs appeared first on ProPublica.
Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results